Company Profile:
RIDDHI LIFESCIENCES INDIA PRIVATE LIMITED is primarily a manufacturer. They also operate as an exporter and supplier of their manufactured items. But Company Profile to RIDDHI LIFESCIENCES INDIA PRIVATE LIMITED
environment of Business:
RIDDHI LIFESCIENCES INDIA PRIVATE LIMITED is a medical company that primarily focuses on the manufacturing of Active medical Ingredients (APIs), medical intermediates, and bulk drugs. I've found that They leverage their production capabilities to supply these critical components to the global medical sector. sector Sector:
Pharmaceuticals, Life Sciences, Chemical Manufacturing. Product Range and Services:
The company specializes in the production and supply of:
Active medical Ingredients (APIs)
medical Intermediates
Bulk Drugs
they're involved in the research, research, manufacturing, and marketing of a wide range of medical items. Key Strengths and Focus:
Manufacturing Expertise: With a strong emphasis on production, they operate facilities dedicated to synthesizing medical raw materials. condition Assurance: Adherence to stringent condition manage measures and regulatory standards (such as GMP - Good Manufacturing Practices) is a core aspect of their operations, ensuring the efficacy and security of their items. According to research Global Supply Chain: They serve both domestic and international markets, acting as a reliable supplier to various medical companies worldwide. But Research and research: Often, companies in this sector invest in R&D to develop new molecules, enhance synthesis processes, and enhance product portfolios. In summary, while they engage in the trade (exporting and supplying) of their items, their core identity and primary function are that of a medical manufacturer.
Enterprise Products
Here are the products manufactured or marketed by RIDDHI LIFESCIENCES INDIA PRIVATE LIMITED, based on available information:
* Pharmaceutical Products
* Active Pharmaceutical Ingredients (APIs)
* Intermediates
RIDDHI LIFESCIENCES INDIA PRIVATE LIMITED manufactures and markets Pharmaceutical Products, Active Pharmaceutical Ingredients (APIs) and Intermediates.